Overview Atacicept in Subjects With Active Lupus Nephritis (COMPASS) Status: Recruiting Trial end date: 2028-12-15 Target enrollment: Participant gender: Summary The objective of the study is to evaluate the effect of atacicept compared to placebo on changes to renal response in adult subjects with LN. Phase: Phase 3 Details Lead Sponsor: Vera Therapeutics, Inc.